Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135096) titled 'Clock Gene PER2-Mediated Lipid Metabolism and Senescence of Pulmonary Epithelial Cells in Interstitial Lung Disease-associated Fibrosis and Melatonin Intervention' on Oct. 23.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

Condition: Interstitial lung disease is one of the most common and clinically significant complications of connective tissue diseases, mainly manifested as pulmonary fibrosis.

Intervention: CTD group:N/A ILD-associated pulmonary fibrosis gro...